LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Elaina M Blair"
  2. AU="Hui Ram Kim"
  3. AU="Litvak, Yael"
  4. AU="Chen, Xiang-Yan"
  5. AU="Honorio Coronado, Eurídice N."
  6. AU="Garny, Hella"
  7. AU="Idris, Zamzuri"
  8. AU="Gao, Xinyu"
  9. AU="Tewari, Srishti"
  10. AU="Behrendt, Ulrike" AU="Behrendt, Ulrike"
  11. AU="Margenthaler, Julie A"
  12. AU="Si, Lian-Jing"
  13. AU="Strand, Torbjørn"
  14. AU=Abdoli Amir

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Improved soluble expression and use of recombinant human renalase.

Clifford S Morrison / Elena E Paskaleva / Marvin A Rios / Thomas R Beusse / Elaina M Blair / Lucy Q Lin / James R Hu / Aidan H Gorby / David R Dodds / William B Armiger / Jonathan S Dordick / Mattheos A G Koffas

PLoS ONE, Vol 15, Iss 11, p e

2020  Band 0242109

Abstract: Electrochemical bioreactor systems have enjoyed significant attention in the past few decades, particularly because of their applications to biobatteries, artificial photosynthetic systems, and microbial electrosynthesis. A key opportunity with ... ...

Abstract Electrochemical bioreactor systems have enjoyed significant attention in the past few decades, particularly because of their applications to biobatteries, artificial photosynthetic systems, and microbial electrosynthesis. A key opportunity with electrochemical bioreactors is the ability to employ cofactor regeneration strategies critical in oxidative and reductive enzymatic and cell-based biotransformations. Electrochemical cofactor regeneration presents several advantages over other current cofactor regeneration systems, such as chemoenzymatic multi-enzyme reactions, because there is no need for a sacrificial substrate and a recycling enzyme. Additionally, process monitoring is simpler and downstream processing is less costly. However, the direct electrochemical reduction of NAD(P)+ on a cathode may produce adventitious side products, including isomers of NAD(P)H that can act as potent competitive inhibitors to NAD(P)H-requiring enzymes such as dehydrogenases. To overcome this limitation, we examined how nature addresses the adventitious formation of isomers of NAD(P)H. Specifically, renalases are enzymes that catalyze the oxidation of 1,2- and 1,6-NAD(P)H to NAD(P)+, yielding an effective recycling of unproductive NAD(P)H isomers. We designed several mutants of recombinant human renalase isoform 1 (rhRen1), expressed them in E. coli BL21(DE3) to enhance protein solubility, and evaluated the activity profiles of the renalase variants against NAD(P)H isomers. The potential for rhRen1 to be employed in engineering applications was then assessed in view of the enzyme's stability upon immobilization. Finally, comparative modeling was performed to assess the underlying reasons for the enhanced solubility and activity of the mutant enzymes.
Schlagwörter Medicine ; R ; Science ; Q
Thema/Rubrik (Code) 572
Sprache Englisch
Erscheinungsdatum 2020-01-01T00:00:00Z
Verlag Public Library of Science (PLoS)
Dokumenttyp Artikel ; Online
Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

Zusatzmaterialien

Kategorien

Zum Seitenanfang